CVM-1118|vasculogenic mimicry (VM) inhibitor

CVM-1118|vasculogenic mimicry (VM) inhibitor

CVM-1118(CVM1118) has high anti-cancer activity, good safety margin, and multiple mechanisms of action targeting cancer, especially its unique ability to inhibit vasculogenic mimicry (VM).

Product name: CVM-1118(CVM1118)|Purity>98%| CAS: N/A|Molecule Formular: C16H11FNNa2O5P|MW: 393.21|Other Namess: CVM-1118,CVM 1118

CVM-1118 is a small molecule NCE (new chemical entity). It has high anti-cancer activity, good safety margin, and multiple mechanisms of action targeting cancer, especially its unique ability to inhibit vasculogenic mimicry (VM). CVM-1118 is currently being developed into a next generation oral anti-cancer drug. CVM-1118 has great potential showing inhibitory effect towards breast, ovarian, colon, and liver cancer in animal models.

For research only, not for human use.